NovaBay Pharma (NYSE: NBY) reported Q2 revenue for the quarter came in at $1.8 million versus the consensus estimate of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE